Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer
Stopped Lack of funding
Conditions
- Atypical Endometrial Hyperplasia
- Endometrial Adenocarcinoma
- Recurrent Endometrial Carcinoma
- Stage IA Endometrial Carcinoma
- Stage IB Endometrial Carcinoma
- Stage II Endometrial Carcinoma
- Stage IIIA Endometrial Carcinoma
- Stage IIIB Endometrial Carcinoma
- Stage IIIC Endometrial Carcinoma
- Stage IVA Endometrial Carcinoma
- Stage IVB Endometrial Carcinoma
Interventions
- DRUG: megestrol acetate
- DEVICE: levonorgestrel-releasing intrauterine system
- OTHER: laboratory biomarker analysis
- OTHER: questionnaire administration
Sponsor
University of Southern California
Collaborators